Single photon emission computed tomography procedure improves accuracy of somatostatin receptor scintigrapy in gastro-entero pancreatic tumours

Italian Journal of Gastroenterology and Hepatology

Volumn 31, Issue 7 SUPPL. 2, 1999, Pages

  Schillaci, O ^a,c   Corleto, V D ^b   Annibale, B ^b   Scopinaro, F ^b   Delle Fave, G ^b  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c University La Sapienza ^*  (Italy)

Author keywords

GEP tumours; Somatostatin receptor scintigraphy; SPECT

Indexed keywords

PENTETREOTIDE IN 111; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR;

ACCURACY; CANCER STAGING; CARCINOID; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DIGESTIVE SYSTEM TUMOR; GLUCAGONOMA; HISTOLOGY; HORMONE RELEASE; HUMAN; INSULINOMA; ISOTOPE LABELING; LIVER METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ISLET CELL CARCINOMA; PANCREAS TUMOR; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SOMATOSTATINOMA; TUMOR LOCALIZATION; VIPOMA;

FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; MALE; NEUROENDOCRINE TUMORS; OCTREOTIDE; PANCREATIC NEOPLASMS; PENTETIC ACID; RECEPTORS, SOMATOSTATIN; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0032701051     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Lamberts SWJ, Chayvialle JA, Krenning EP. The visualization of gastroenteropancreatic endocrine tumors. Digestion 1993;54 (Suppl. 1):92-7.
2. Moertel CG. An odyssey in the land of small tumors. J Clin Oncol 1987;5:1503-22.
3. Reubi JC, Kvols LK, Waser B, Nagorney DM, Heitz PU, Charboneau JW, et al. Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas. Cancer Res 1990;50:5969-77.
4. Bakker WH, Krenning EP, Breeman WA, Kooij PPM, Reubi JC, Koper JW, et al. In vivo use of a radioidinated somatostatin analogue: dynamics, metabolism, and binding to somatostatin receptor-positive tumors in man. J Nucl Med 1991;32:1184-9.
5. Lamberts SWJ, Bakker WH, Reubi JC, Krenning EP. Somatostatin receptors imaging in the localization of endocrine tumors. N Engl J Med 1990;323:1246-9.
6. Kvols LK, Brown ML, O'Connor MK, Hung JC, Hayostek RJ, Reubi JC, et al. Evaluation of a radiolabeled somatostatin analog (1-123 Octreotide) in the detection and localization of carcinoid and islet cell tumors. Radiology 1993;49:1583-91.
7. 1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation. Life Sci 1991;49:1583-91.
8. Krenning EP, Bakker WH, Kooij PPM, Breeman WAP, Oei HY, de Jong M, et al. Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe 1-Octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-Octreotide. J Nucl Med 1992;33:652-8.
9. Corleto VD, Scopinaro F, Angeletti S, Materia A, Basso N, Polettini E, et al. Somatostatin receptor localization of pancreatic endocrine tumors. World J Surg 1996;20:241-4.
10. Jamar F, Fiasse R, Leners N, Pauwels S. Somatostatin receptor imaging with indium-111-pentatreotide in gastroenteropancreatic neuroendocrine tumors: safety, efficacy and impact on patient management. J Nucl Med 1995;36:542-9.
11. 3]octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993;20:716-31.
12. Schillaci O, Scopinaro F, Angeletti S, Tavolaro R, Danieli R, Annibale B, et al. SPECT improves accuracy of somatostatin recep-tor scintigraphy in abdominal carcinoid tumors. J Nucl Med 1996;37:1452-6.
13. John M, Meyerhof W, Waser B. Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2. Gut 1996;38:33-9.
14. Krenning EP, Kwekkeboom DJ, Oei HY, de Jong RJB, Dop FJ, Reubi JC, et al. Somatostatin-receptor scintigraphy in gastroenteropancreatic tumors: an overview of European results. Ann New York Acad Sci 1994;733:416-24.
15. 111In-pentatreotide detection of gastrinoma before and after surgery. Anticancer Res 1997;17:1757-60.
16. Kwekkeboom DS, Krenning EP, Bakker WH, Oei HJ, Kooij PPM, Lamberts SWJ. Somatostatin analogue scintigraphy in carcinoid tumors. Eur J Nucl Med 1993;20:283-92.
17. Angeletti S, Corleto VD, Schillaci O, Marignani M, Annibale B, Moretti A, et al. Use of the somatostatin analogue octreotide to localise and manage somatostatin-producing tumours. Gut 1998;42:792-4.
18. 111In-Octreoscan and SPECT. J Nucl Biol Med 1994;38:341-2.
19. Ahlman H, Tisell LE, Wangberg B, Nilsson O, Forssell Aronsson E, Fialling M. Somatostatin receptor imaging in patients with neuroendocrine tumors: preoperative and postoperative scintigraphy and intraoperative use of a scintillation detector. Semin Oncol 1994;21(Suppl. 13):21-8.